Clinical Trial Update: Effect of Lidocaine in Antiarrhythmic Dosage on Postoperative Cognitive Dysfunction in Supratentorial Craniotomy Dysfunction in Supratentorial Craniotomy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated lidocaine at antiarrhythmic dosing for postoperative cognitive dysfunction following supratentorial craniotomy; the study has…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Cognitive Dysfunction

Drugs mentioned

• Lidocaine (Lidocaine)

Snippet

Sponsor: Capital Medical University | Conditions: Supratentorial Craniotomy Dysfunction | Phase 2 | Status: COMPLETED